YFR006W Antibody

What is YFR006W and why is it studied in yeast research?

YFR006W is a protein found in Saccharomyces cerevisiae (baker's yeast, strain ATCC 204508/S288c) and is cataloged with the UniProt accession number P43590. This protein has gained interest in yeast research due to its potential roles in cellular processes. Studying YFR006W contributes to our understanding of yeast biology and potentially conserved cellular mechanisms across eukaryotes.

For productive research, it's crucial to use proper controls when investigating this protein. The YCharOS initiative has demonstrated that knockout validation is essential for confirming antibody specificity, as this approach can identify antibodies that might cross-react with other proteins and produce misleading results .

What validated applications are appropriate for YFR006W antibody?

The YFR006W antibody has been validated for specific research applications including:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blotting (WB)

When designing experiments, researchers should ensure proper identification of the antigen and validate antibody performance in their specific experimental context . Despite validated applications, the YCharOS initiative recommends that researchers perform at least siRNA/shRNA knockdown controls in their relevant systems to confirm selectivity under their specific experimental conditions, which may differ from standardized characterization pipelines .

What are the optimal storage and handling conditions for YFR006W antibody?

The YFR006W antibody should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided to maintain antibody integrity and functionality. The antibody is typically supplied in liquid form with a storage buffer containing:

• 0.03% Proclin 300 (preservative)

• 50% Glycerol

• 0.01M PBS, pH 7.4

These specifications are critical for maintaining antibody stability and performance. Researchers should document storage conditions and freeze-thaw cycles as part of their experimental records to support reproducibility.

How should I validate the specificity of YFR006W antibody in my experimental system?

Validating antibody specificity is crucial for research integrity. For YFR006W antibody, consider implementing these validation steps:

• Perform knockout or knockdown experiments using CRISPR-Cas9 or RNAi approaches to verify signal absence in samples lacking the target

• Include positive controls using recombinant YFR006W protein

• Test for cross-reactivity with closely related proteins

• Compare results across multiple detection methods (e.g., Western blot and immunofluorescence)

The reproducibility crisis in antibody research, highlighted by YCharOS findings, demonstrates that many commercially available antibodies may not perform as advertised. Their work has resulted in companies altering recommended usages or removing over 200 antibodies from catalogs , emphasizing the importance of rigorous validation.

What experimental controls are essential when using YFR006W antibody in redox biology studies?

When studying YFR006W in redox biology contexts, specific controls are necessary to ensure reliable results:

• Include oxidative stress controls: Compare samples with and without oxidative stress inducers to establish baseline signal

• Use reducing and non-reducing conditions: Run parallel experiments under both conditions to identify redox-sensitive interactions

• Implement genetic controls: Use deletion mutants (e.g., Δgrx2, Δprx1) as demonstrated in redox research to validate antibody specificity in different redox states

• Include glutathionylation controls: If studying post-translational modifications, run controls for glutathionylation detection alongside your YFR006W detection

Research has shown that redox conditions can significantly affect protein detection. For example, studies examining glutathionylation found significant increases in the double mutant Δgrx2Δprx1, highlighting the importance of appropriate controls when studying proteins under varying redox conditions .

How can I optimize Western blot protocols for YFR006W detection?

Optimizing Western blot protocols for YFR006W requires attention to several critical factors:

• Sample preparation: Use freshly prepared yeast lysates with protease inhibitors to prevent degradation

• Protein loading: Load 20-50 μg of total protein per lane, with equivalent loading confirmed by Ponceau S staining

• Buffer selection: For standard detection, use reducing buffers with β-mercaptoethanol; for studying modifications like glutathionylation, use non-reducing conditions

• Primary antibody dilution: Begin with 1:1000 dilution and optimize as needed

• Washing stringency: Use multiple washes (3-5 times) with TBS-T to reduce background

• Signal detection: Use chemiluminescent detection with appropriate exposure time to avoid signal saturation

When studying redox modifications, researchers should note that protein loading in non-reducing buffer is essential for glutathionylation detection, as demonstrated in previous studies . Additionally, controls such as Ponceau S staining help ensure equivalent protein loading, which is critical for quantitative comparisons.

What approaches can resolve inconsistent results when using YFR006W antibody?

When facing inconsistent results with YFR006W antibody, implement this systematic troubleshooting approach:

• Verify antibody quality: Test a new lot or aliquot to rule out antibody degradation

• Optimize protein extraction: Compare different lysis methods to ensure complete protein extraction while preserving epitope integrity

• Adjust buffer conditions: Modify salt concentration and detergents to optimize antibody-epitope interaction

• Implement blocking optimization: Test different blocking agents (BSA vs. milk) to reduce background

• Control for post-translational modifications: Consider that modifications may affect epitope recognition

• Validate with alternative methods: Confirm results using orthogonal approaches

The YCharOS initiative has shown that antibody performance can vary significantly between experimental conditions and cell types. Their recommendation is that end users should perform at least siRNA/shRNA knockdown controls in their relevant system to confirm selectivity under their specific experimental conditions .

Can YFR006W antibody be effectively used for immunoprecipitation studies?

While the YFR006W antibody product information does not specifically list immunoprecipitation (IP) among validated applications , researchers interested in this application should:

• Perform pilot experiments with positive controls

• Optimize antibody:bead:lysate ratios

• Test different binding conditions (temperature, duration, buffer composition)

• Include appropriate negative controls (non-specific IgG, lysate from knockout strains)

• Validate results by Western blot analysis of immunoprecipitated material

Based on immunoprecipitation methodologies described in related yeast protein studies, researchers should consider using 1-5 μg of antibody per 100-500 μg of protein lysate, with verification of results by Western blot .

How does gene deletion methodology impact YFR006W antibody validation studies?

Gene deletion approaches are crucial for validating YFR006W antibody specificity and should be implemented with attention to several factors:

• Strain selection considerations:

  • Use established deletion collections (e.g., Euroscarf collection)

  • Verify genotype by PCR after deletion

  • Confirm phenotype by Western blot

• Deletion strategy impacts:

  • Complete gene deletion vs. targeted epitope removal

  • Effect of marker insertion on neighboring gene expression

  • Potential compensatory mechanisms in knockout strains

The methodological approach used in creating deletion strains can significantly impact validation results. For example, research on related yeast proteins shows that strain construction typically involves replacing the target gene with a selection marker (e.g., LEU2, KanMX4), followed by confirmation through both genotype (PCR) and phenotype (Western blot) verification .

What considerations are important when studying YFR006W across different yeast strains?

When investigating YFR006W across different yeast strains, researchers should account for:

• Strain-specific expression variations:

  • Laboratory strains (S288C) vs. wild isolates

  • Haploid vs. diploid expression patterns

  • Growth phase-dependent expression changes

• Experimental design adaptations:

  • Adjust protein extraction protocols for strain-specific cell wall differences

  • Normalize data to account for strain-specific expression levels

  • Include strain-specific positive controls

Studies examining yeast proteins across different strains have shown that strain background can significantly affect protein expression and modification patterns. For instance, when studying oxidative stress responses, phenotypic differences were observed between wild-type strains and various mutants, highlighting the importance of proper strain selection and characterization .

What are best practices for quantifying YFR006W protein expression levels?

For accurate quantification of YFR006W protein expression, researchers should implement these best practices:

• Technical approach:

  • Use appropriate loading controls (housekeeping proteins)

  • Implement standard curve with recombinant protein when possible

  • Capture images within linear detection range

  • Use digital image analysis software with background subtraction

• Normalization strategy:

  • Normalize to total protein (Ponceau S) rather than single housekeeping proteins

  • Present data as relative expression compared to control conditions

  • Include biological replicates (n≥3) with appropriate statistical analysis

When analyzing redox-sensitive proteins, researchers have demonstrated the importance of proper control selection and normalization strategies. Studies examining glutathionylation patterns, for instance, used specific antibody detection followed by image analysis using systems like Multi Gauge version 3.0 .

How can YFR006W antibody be integrated into multi-omics research approaches?

Integrating YFR006W antibody-based detection into multi-omics approaches requires careful experimental design:

• Coordinated sample preparation:

  • Process parallel samples for proteomics, transcriptomics, and antibody-based detection

  • Use consistent lysis and preparation methods to enable direct comparisons

• Data integration strategies:

  • Correlate protein levels (antibody-based) with transcript levels (RNA-seq)

  • Compare antibody-detected post-translational modifications with mass spectrometry data

  • Integrate with functional assays to correlate expression with phenotype

Multi-omics approaches have been successfully applied in yeast research. For example, studies have combined expression analysis using DNA microarrays with proteomic approaches to understand the relationships between transcription, protein levels, and protein modifications under various conditions .

How should researchers address antibody batch variation when working with YFR006W antibody?

Antibody batch variation can significantly impact experimental reproducibility. Researchers should implement these quality control measures:

• Batch validation protocol:

  • Test each new lot against a reference lot using identical samples

  • Document lot numbers and validation results

  • Maintain a reference sample for cross-batch comparisons

• Experimental design considerations:

  • Complete experimental series with a single antibody lot when possible

  • Include internal controls for normalization across batches

  • Report lot numbers in publications to improve reproducibility

The YCharOS initiative has highlighted the importance of antibody validation and quality control. Their work with major antibody manufacturers has resulted in companies altering recommended usages or removing unreliable antibodies from catalogs, emphasizing the critical nature of antibody quality control .

What reporting standards should be followed when publishing research using YFR006W antibody?

When publishing research using YFR006W antibody, adhere to these reporting standards to ensure reproducibility:

• Essential antibody information:

  • Product code (e.g., CSB-PA337455XA01SVG)

  • Supplier information

  • Lot number

  • RRID (Research Resource Identifier) if available

  • Dilutions and incubation conditions used

• Validation evidence:

  • Document specificity controls (knockout/knockdown)

  • Report optimization procedures

  • Include raw blot/image data with molecular weight markers

  • Describe image acquisition and processing methods

The standardized reporting of antibody information is essential for research reproducibility. YCharOS and other initiatives emphasize that despite progress in antibody characterization, the scientific community needs improved standards for reporting antibody usage in research .